カテゴリー： 世界, 医療/バイオ, LP Information

世界の神経ブロック注射市場予測 2023年-2029年

【英語タイトル】Global Nerve Block Injection Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC09018）・商品コード：LP23DC09018
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の神経ブロック注射市場」は、過去の販売実績から2022年の世界の神経ブロック注射の総販売量を検討し、2023年から2029年の予測される神経ブロック注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の神経ブロック注射の市場規模を掲載し、XXX百万米ドル規模の世界の神経ブロック注射市場の詳細な分析を提供します。本インサイトレポートは、世界の神経ブロック注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の神経ブロック注射市場における各社の独自のポジションをより深く理解するために、神経ブロック注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の神経ブロック注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。神経ブロック注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。神経ブロック注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。神経ブロック注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

神経ブロック注射の世界主要メーカーとしては、Pfizer、 Pacira、 Fresenius Kabi、 Aspen Pharmacare、 AstraZeneca、 Eugia US、 Aurobindo、 Akorn、 Somerset Pharma、 Amphastar Pharmaceuticals、 Hikmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の神経ブロック注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では神経ブロック注射市場をセグメンテーションし、種類別 (エステル系局所麻酔薬、アミド系局所麻酔薬)、用途別 (病院、クリニック、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：エステル系局所麻酔薬、アミド系局所麻酔薬

・用途別区分：病院、クリニック、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の神経ブロック注射市場の10年間の市場状況・展望は？
・世界および地域別に見た神経ブロック注射市場成長の要因は何か？
・神経ブロック注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・神経ブロック注射のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：神経ブロック注射の年間販売量2018-2029、地域別現状・将来分析
・神経ブロック注射の種類別セグメント：エステル系局所麻酔薬、アミド系局所麻酔薬
・神経ブロック注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・神経ブロック注射の用途別セグメント：病院、クリニック、その他
・神経ブロック注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の神経ブロック注射市場
・企業別のグローバル神経ブロック注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別の神経ブロック注射の年間売上：2018-2023年の売上、市場シェア
・企業別の神経ブロック注射販売価格
・主要企業の神経ブロック注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

神経ブロック注射の地域別レビュー
・地域別の神経ブロック注射市場規模2018-2023：年間販売量、売上
・主要国別の神経ブロック注射市場規模2018-2023：年間販売量、売上
・南北アメリカの神経ブロック注射販売の成長
・アジア太平洋の神経ブロック注射販売の成長
・ヨーロッパの神経ブロック注射販売の成長
・中東・アフリカの神経ブロック注射販売の成長

南北アメリカ市場
・南北アメリカの国別の神経ブロック注射販売量、売上（2018-2023）
・南北アメリカの神経ブロック注射の種類別販売量
・南北アメリカの神経ブロック注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の神経ブロック注射販売量、売上（2018-2023）
・アジア太平洋の神経ブロック注射の種類別販売量
・アジア太平洋の神経ブロック注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の神経ブロック注射販売量、売上（2018-2023）
・ヨーロッパの神経ブロック注射の種類別販売量
・ヨーロッパの神経ブロック注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の神経ブロック注射販売量、売上（2018-2023）
・中東・アフリカの神経ブロック注射の種類別販売量
・中東・アフリカの神経ブロック注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・神経ブロック注射の製造コスト構造分析
・神経ブロック注射の製造プロセス分析
・神経ブロック注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・神経ブロック注射の主要なグローバル販売業者
・神経ブロック注射の主要なグローバル顧客

地域別の神経ブロック注射市場予測レビュー
・地域別の神経ブロック注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・神経ブロック注射の種類別市場規模予測
・神経ブロック注射の用途別市場規模予測

主要企業分析
Pfizer、 Pacira、 Fresenius Kabi、 Aspen Pharmacare、 AstraZeneca、 Eugia US、 Aurobindo、 Akorn、 Somerset Pharma、 Amphastar Pharmaceuticals、 Hikma
・企業情報
・神経ブロック注射製品
・神経ブロック注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Nerve Block Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nerve Block Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nerve Block Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nerve Block Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nerve Block Injection players cover Pfizer, Pacira, Fresenius Kabi, Aspen Pharmacare, AstraZeneca, Eugia US, Aurobindo, Akorn and Somerset Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nerve block injection is a local anesthetic used during surgery to control pain and reduce or eliminate the use of opioids for acute postoperative pain.
LPI (LP Information)’ newest research report, the “Nerve Block Injection Industry Forecast” looks at past sales and reviews total world Nerve Block Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Nerve Block Injection sales for 2023 through 2029. With Nerve Block Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nerve Block Injection industry.
This Insight Report provides a comprehensive analysis of the global Nerve Block Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nerve Block Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nerve Block Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nerve Block Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nerve Block Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Nerve Block Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Esters Local Anesthetics
Amide Local Anesthetics
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Pacira
Fresenius Kabi
Aspen Pharmacare
AstraZeneca
Eugia US
Aurobindo
Akorn
Somerset Pharma
Amphastar Pharmaceuticals
Hikma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nerve Block Injection market?
What factors are driving Nerve Block Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nerve Block Injection market opportunities vary by end market size?
How does Nerve Block Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nerve Block Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nerve Block Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nerve Block Injection by Country/Region, 2018, 2022 & 2029
2.2 Nerve Block Injection Segment by Type
2.2.1 Esters Local Anesthetics
2.2.2 Amide Local Anesthetics
2.3 Nerve Block Injection Sales by Type
2.3.1 Global Nerve Block Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Nerve Block Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nerve Block Injection Sale Price by Type (2018-2023)
2.4 Nerve Block Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Nerve Block Injection Sales by Application
2.5.1 Global Nerve Block Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Nerve Block Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nerve Block Injection Sale Price by Application (2018-2023)
3 Global Nerve Block Injection by Company
3.1 Global Nerve Block Injection Breakdown Data by Company
3.1.1 Global Nerve Block Injection Annual Sales by Company (2018-2023)
3.1.2 Global Nerve Block Injection Sales Market Share by Company (2018-2023)
3.2 Global Nerve Block Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Nerve Block Injection Revenue by Company (2018-2023)
3.2.2 Global Nerve Block Injection Revenue Market Share by Company (2018-2023)
3.3 Global Nerve Block Injection Sale Price by Company
3.4 Key Manufacturers Nerve Block Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nerve Block Injection Product Location Distribution
3.4.2 Players Nerve Block Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nerve Block Injection by Geographic Region
4.1 World Historic Nerve Block Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Nerve Block Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nerve Block Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nerve Block Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Nerve Block Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nerve Block Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nerve Block Injection Sales Growth
4.4 APAC Nerve Block Injection Sales Growth
4.5 Europe Nerve Block Injection Sales Growth
4.6 Middle East & Africa Nerve Block Injection Sales Growth
5 Americas
5.1 Americas Nerve Block Injection Sales by Country
5.1.1 Americas Nerve Block Injection Sales by Country (2018-2023)
5.1.2 Americas Nerve Block Injection Revenue by Country (2018-2023)
5.2 Americas Nerve Block Injection Sales by Type
5.3 Americas Nerve Block Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nerve Block Injection Sales by Region
6.1.1 APAC Nerve Block Injection Sales by Region (2018-2023)
6.1.2 APAC Nerve Block Injection Revenue by Region (2018-2023)
6.2 APAC Nerve Block Injection Sales by Type
6.3 APAC Nerve Block Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nerve Block Injection by Country
7.1.1 Europe Nerve Block Injection Sales by Country (2018-2023)
7.1.2 Europe Nerve Block Injection Revenue by Country (2018-2023)
7.2 Europe Nerve Block Injection Sales by Type
7.3 Europe Nerve Block Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nerve Block Injection by Country
8.1.1 Middle East & Africa Nerve Block Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nerve Block Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Nerve Block Injection Sales by Type
8.3 Middle East & Africa Nerve Block Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nerve Block Injection
10.3 Manufacturing Process Analysis of Nerve Block Injection
10.4 Industry Chain Structure of Nerve Block Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nerve Block Injection Distributors
11.3 Nerve Block Injection Customer
12 World Forecast Review for Nerve Block Injection by Geographic Region
12.1 Global Nerve Block Injection Market Size Forecast by Region
12.1.1 Global Nerve Block Injection Forecast by Region (2024-2029)
12.1.2 Global Nerve Block Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nerve Block Injection Forecast by Type
12.7 Global Nerve Block Injection Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Nerve Block Injection Product Portfolios and Specifications
13.1.3 Pfizer Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Pacira
13.2.1 Pacira Company Information
13.2.2 Pacira Nerve Block Injection Product Portfolios and Specifications
13.2.3 Pacira Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pacira Main Business Overview
13.2.5 Pacira Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Nerve Block Injection Product Portfolios and Specifications
13.3.3 Fresenius Kabi Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Aspen Pharmacare
13.4.1 Aspen Pharmacare Company Information
13.4.2 Aspen Pharmacare Nerve Block Injection Product Portfolios and Specifications
13.4.3 Aspen Pharmacare Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aspen Pharmacare Main Business Overview
13.4.5 Aspen Pharmacare Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Nerve Block Injection Product Portfolios and Specifications
13.5.3 AstraZeneca Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Eugia US
13.6.1 Eugia US Company Information
13.6.2 Eugia US Nerve Block Injection Product Portfolios and Specifications
13.6.3 Eugia US Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eugia US Main Business Overview
13.6.5 Eugia US Latest Developments
13.7 Aurobindo
13.7.1 Aurobindo Company Information
13.7.2 Aurobindo Nerve Block Injection Product Portfolios and Specifications
13.7.3 Aurobindo Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Aurobindo Main Business Overview
13.7.5 Aurobindo Latest Developments
13.8 Akorn
13.8.1 Akorn Company Information
13.8.2 Akorn Nerve Block Injection Product Portfolios and Specifications
13.8.3 Akorn Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Akorn Main Business Overview
13.8.5 Akorn Latest Developments
13.9 Somerset Pharma
13.9.1 Somerset Pharma Company Information
13.9.2 Somerset Pharma Nerve Block Injection Product Portfolios and Specifications
13.9.3 Somerset Pharma Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Somerset Pharma Main Business Overview
13.9.5 Somerset Pharma Latest Developments
13.10 Amphastar Pharmaceuticals
13.10.1 Amphastar Pharmaceuticals Company Information
13.10.2 Amphastar Pharmaceuticals Nerve Block Injection Product Portfolios and Specifications
13.10.3 Amphastar Pharmaceuticals Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Amphastar Pharmaceuticals Main Business Overview
13.10.5 Amphastar Pharmaceuticals Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Nerve Block Injection Product Portfolios and Specifications
13.11.3 Hikma Nerve Block Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Nerve Block Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nerve Block Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Esters Local Anesthetics
Table 4. Major Players of Amide Local Anesthetics
Table 5. Global Nerve Block Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Nerve Block Injection Sales Market Share by Type (2018-2023)
Table 7. Global Nerve Block Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nerve Block Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Nerve Block Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Nerve Block Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Nerve Block Injection Sales Market Share by Application (2018-2023)
Table 12. Global Nerve Block Injection Revenue by Application (2018-2023)
Table 13. Global Nerve Block Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Nerve Block Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Nerve Block Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Nerve Block Injection Sales Market Share by Company (2018-2023)
Table 17. Global Nerve Block Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nerve Block Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Nerve Block Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Nerve Block Injection Producing Area Distribution and Sales Area
Table 21. Players Nerve Block Injection Products Offered
Table 22. Nerve Block Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nerve Block Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Nerve Block Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nerve Block Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nerve Block Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nerve Block Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Nerve Block Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nerve Block Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nerve Block Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nerve Block Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Nerve Block Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Nerve Block Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nerve Block Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Nerve Block Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Nerve Block Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Nerve Block Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Nerve Block Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Nerve Block Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nerve Block Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Nerve Block Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Nerve Block Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Nerve Block Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Nerve Block Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Nerve Block Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nerve Block Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Nerve Block Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Nerve Block Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Nerve Block Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Nerve Block Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nerve Block Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nerve Block Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nerve Block Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Nerve Block Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nerve Block Injection
Table 58. Key Market Challenges & Risks of Nerve Block Injection
Table 59. Key Industry Trends of Nerve Block Injection
Table 60. Nerve Block Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nerve Block Injection Distributors List
Table 63. Nerve Block Injection Customer List
Table 64. Global Nerve Block Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Nerve Block Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nerve Block Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Nerve Block Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nerve Block Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Nerve Block Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nerve Block Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Nerve Block Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nerve Block Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Nerve Block Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nerve Block Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Nerve Block Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nerve Block Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Nerve Block Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Nerve Block Injection Product Portfolios and Specifications
Table 80. Pfizer Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Pacira Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Pacira Nerve Block Injection Product Portfolios and Specifications
Table 85. Pacira Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pacira Main Business
Table 87. Pacira Latest Developments
Table 88. Fresenius Kabi Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Kabi Nerve Block Injection Product Portfolios and Specifications
Table 90. Fresenius Kabi Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Fresenius Kabi Main Business
Table 92. Fresenius Kabi Latest Developments
Table 93. Aspen Pharmacare Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Aspen Pharmacare Nerve Block Injection Product Portfolios and Specifications
Table 95. Aspen Pharmacare Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Aspen Pharmacare Main Business
Table 97. Aspen Pharmacare Latest Developments
Table 98. AstraZeneca Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Nerve Block Injection Product Portfolios and Specifications
Table 100. AstraZeneca Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Eugia US Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Eugia US Nerve Block Injection Product Portfolios and Specifications
Table 105. Eugia US Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Eugia US Main Business
Table 107. Eugia US Latest Developments
Table 108. Aurobindo Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Aurobindo Nerve Block Injection Product Portfolios and Specifications
Table 110. Aurobindo Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Aurobindo Main Business
Table 112. Aurobindo Latest Developments
Table 113. Akorn Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Akorn Nerve Block Injection Product Portfolios and Specifications
Table 115. Akorn Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Akorn Main Business
Table 117. Akorn Latest Developments
Table 118. Somerset Pharma Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Somerset Pharma Nerve Block Injection Product Portfolios and Specifications
Table 120. Somerset Pharma Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Somerset Pharma Main Business
Table 122. Somerset Pharma Latest Developments
Table 123. Amphastar Pharmaceuticals Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Amphastar Pharmaceuticals Nerve Block Injection Product Portfolios and Specifications
Table 125. Amphastar Pharmaceuticals Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Amphastar Pharmaceuticals Main Business
Table 127. Amphastar Pharmaceuticals Latest Developments
Table 128. Hikma Basic Information, Nerve Block Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Hikma Nerve Block Injection Product Portfolios and Specifications
Table 130. Hikma Nerve Block Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Hikma Main Business
Table 132. Hikma Latest Developments
List of Figures
Figure 1. Picture of Nerve Block Injection
Figure 2. Nerve Block Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nerve Block Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nerve Block Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nerve Block Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Esters Local Anesthetics
Figure 10. Product Picture of Amide Local Anesthetics
Figure 11. Global Nerve Block Injection Sales Market Share by Type in 2022
Figure 12. Global Nerve Block Injection Revenue Market Share by Type (2018-2023)
Figure 13. Nerve Block Injection Consumed in Hospital
Figure 14. Global Nerve Block Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Nerve Block Injection Consumed in Clinic
Figure 16. Global Nerve Block Injection Market: Clinic (2018-2023) & (K Units)
Figure 17. Nerve Block Injection Consumed in Others
Figure 18. Global Nerve Block Injection Market: Others (2018-2023) & (K Units)
Figure 19. Global Nerve Block Injection Sales Market Share by Application (2022)
Figure 20. Global Nerve Block Injection Revenue Market Share by Application in 2022
Figure 21. Nerve Block Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Nerve Block Injection Sales Market Share by Company in 2022
Figure 23. Nerve Block Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Nerve Block Injection Revenue Market Share by Company in 2022
Figure 25. Global Nerve Block Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Nerve Block Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Nerve Block Injection Sales 2018-2023 (K Units)
Figure 28. Americas Nerve Block Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Nerve Block Injection Sales 2018-2023 (K Units)
Figure 30. APAC Nerve Block Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Nerve Block Injection Sales 2018-2023 (K Units)
Figure 32. Europe Nerve Block Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Nerve Block Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Nerve Block Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Nerve Block Injection Sales Market Share by Country in 2022
Figure 36. Americas Nerve Block Injection Revenue Market Share by Country in 2022
Figure 37. Americas Nerve Block Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Nerve Block Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Nerve Block Injection Sales Market Share by Region in 2022
Figure 44. APAC Nerve Block Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Nerve Block Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Nerve Block Injection Sales Market Share by Application (2018-2023)
Figure 47. China Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Nerve Block Injection Sales Market Share by Country in 2022
Figure 55. Europe Nerve Block Injection Revenue Market Share by Country in 2022
Figure 56. Europe Nerve Block Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Nerve Block Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Nerve Block Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Nerve Block Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Nerve Block Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Nerve Block Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Nerve Block Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Nerve Block Injection in 2022
Figure 73. Manufacturing Process Analysis of Nerve Block Injection
Figure 74. Industry Chain Structure of Nerve Block Injection
Figure 75. Channels of Distribution
Figure 76. Global Nerve Block Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Nerve Block Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Nerve Block Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Nerve Block Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Nerve Block Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Nerve Block Injection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の神経ブロック注射市場予測 2023年-2029年] (コード：LP23DC09018)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経ブロック注射市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経皮電気神経刺激ユニット市場予測 2023年-2029年
  • 世界のワックスブロック保管キャビネット市場予測 2023年-2029年
  • 世界のワックスブロック保管キャビネット市場予測 2023年-2029年
  • 世界のラジウム-223注射市場予測 2023年-2029年
  • 世界のトシリズマブ注射市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆